Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Asset disposition
|
|
Translate Bio, Inc. (TBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/24/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/22/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/22/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/16/2021 |
4/A
| BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Disposed of 18,044,239 shares
@ $38, valued at
$685.7M
|
|
| 09/16/2021 |
SC 13D/A
| Baupost Group reports a 0% stake in Translate Bio, Inc. |
| 09/14/2021 |
4
| Sutherland Everett Rand (President) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 300,000 options to buy
@ $16.37, valued at
$4.9M
|
|
| 09/14/2021 |
4
| Smith Brendan (CFO) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 201,800 options to buy
@ $19.23, valued at
$3.9M
|
|
| 09/14/2021 |
4
| Renaud Ronald C JR (CEO) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 503,231 shares
@ $38, valued at
$19.1M
Sold 409,913 shares
@ $38, valued at
$15.6M
Sold 40,909 shares
@ $38, valued at
$1.6M
Sold 500,000 options to buy
@ $7.95, valued at
$4M
Sold 525,000 options to buy
@ $7.66, valued at
$4M
Sold 325,000 options to buy
@ $23.82, valued at
$7.7M
Sold 1,071,009 options to buy
@ $7.39, valued at
$7.9M
Sold 89,996 options to buy
@ $8.34, valued at
$750.6k
|
|
| 09/14/2021 |
4/A
| Renaud Ronald C JR (CEO) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Exercised 9,026 options to buy
@ $7.39, valued at
$66.7k
|
|
| 09/14/2021 |
4
| Burgess Paul D. (COO, CLO) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 71,833 shares
@ $38, valued at
$2.7M
Sold 219,652 options to buy
@ $7.39, valued at
$1.6M
Sold 69,953 options to buy
@ $8.34, valued at
$583.4k
Sold 150,000 options to buy
@ $7.95, valued at
$1.2M
Sold 150,000 options to buy
@ $7.66, valued at
$1.1M
Sold 90,000 options to buy
@ $23.82, valued at
$2.1M
|
|
| 09/14/2021 |
4
| Plenge Robert M (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 37,800 options to buy
@ $12.36, valued at
$467.2k
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 09/14/2021 |
4
| Meyer Robert J. (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 37,800 options to buy
@ $7.49, valued at
$283.1k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 09/14/2021 |
4
| Hughes Owen (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 29,860 shares
@ $38, valued at
$1.1M
Sold 38,135 options to buy
@ $7.39, valued at
$281.8k
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 09/14/2021 |
4
| Demetri George (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 37,800 options to buy
@ $10.15, valued at
$383.7k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 09/14/2021 |
4
| FORMELA JEAN FRANCOIS (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 2,055,063 shares
@ $38, valued at
$78.1M
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
Sold 37,800 options to buy
@ $8.34, valued at
$315.3k
|
|
| 09/14/2021 |
4
| Demetri George (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 37,800 options to buy
@ $10.15, valued at
$383.7k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 09/14/2021 |
4
| Beckman Daniella (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Sold 67,995 options to buy
@ $7.39, valued at
$502.5k
Sold 18,900 options to buy
@ $10.2, valued at
$192.8k
Sold 18,900 options to buy
@ $15.33, valued at
$289.7k
Sold 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/14/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 09/14/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 09/14/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 09/14/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 09/14/2021 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 09/14/2021 |
4
| Sanofi (10% Owner) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Bought 51,467,612 shares
@ $38, valued at
$1955.8M
Bought 20,515,985 shares
@ $38, valued at
$779.6M
|
|
| 09/14/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 09/14/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/14/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/10/2021 |
SC 13G/A
| FMR LLC reports a 0.3% stake in TRANSLATE BIO INC |
| 09/07/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/27/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/27/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|